Robert Coffin, CEO of Replimune, pioneers the first oncolytic immunotherapy

Editorial owner accountable for this profile route.

Estimated reading time at standard editorial pace.

Date this profile last entered editorial circulation.

Date this profile last entered editorial circulation.

Primary geography where current signals are most visible.

Structured briefing used for sector and risk comparison.